Intalfa 3miu Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Interferon Alpha 2B (3miu)
Overview Intalfa 3miu Injection
Alfaferon 3 million IU Injection treats chronic hepatitis B (HBV) and C (HCV) infections, multiple myeloma, follicular lymphoma, and hairy cell leukemia. Administered intravenously by a healthcare professional, treatment duration depends on individual response and is determined by your physician. Strict adherence to your doctor's instructions is crucial; incorrect dosage may lead to severe adverse effects. Therapeutic benefits may not be immediately apparent, requiring weeks or months; discontinue use only as directed. Common side effects include headache, dizziness, sleeplessness, nausea, and vomiting. Reduced blood cell counts, increasing infection risk, necessitate reporting fever, chills, dyspnea, unusual bleeding/bruising, or dark urine. Regular blood tests monitor blood cell counts, thyroid function, liver and kidney health, and electrolyte levels. Prior to treatment, disclose any liver or kidney disease, or pre-existing mental health conditions including mood swings, depression, visual disturbances, or suicidal ideation, as this medication may exacerbate these issues. Inform your healthcare provider of all other medications, as interactions are possible. This injection is contraindicated during pregnancy and breastfeeding; effective contraception is essential for both partners throughout treatment.
Primary Ingredients of Intalfa 3miu Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Intalfa 3miu Injection
Long-term hepatitis B (HBV) infection, persistent hepatitis C (HCV) infection, myeloma, follicular lymphoma, and hairy cell leukemia.
Major Benefits of Intalfa 3miu Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Intalfa 3miu Injection:
- Headache
- Dizziness
- Blurred vision
- Insomnia (difficulty in sleeping)
- Vomiting
- Nausea
- Dryness in mouth
- Abdominal pain
- Agitation
- Sore throat
- Decreased white blood cell count
- Viral infection
- Indigestion
- Fatigue
- Fever
- Anxiety
- Depression
- Decreased appetite
- Cough
- Impaired concentration
- Nervousness
- Stomatitis (Inflammation of the mouth)
How to use Intalfa 3miu Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Intalfa 3miu Injection works:
Intalfa 3-million-unit injection regulates the body's immunological response.
SAFETY ADVICE
AlcoholUNSAFE
Combining Intalfa 3miu Injection and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Intalfa 3miu Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against these risks prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Intalfa 3miu Injection without significant harm to their infants. Available human data indicates minimal risk to the nursing child.
DrivingUNSAFE
Intalfa 3miu Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyUNSAFE
The use of Intalfa 3miu Injection is potentially hazardous for individuals with kidney disorders and is best avoided. Medical advice is recommended. Patients exhibiting renal dysfunction require careful monitoring.
LiverCAUTION
For patients with severe hepatic impairment, Intalfa 3miu Injection requires careful administration. Dosage modification of Intalfa 3miu Injection may be necessary. Physician consultation is advised.
What if you forget to take Intalfa 3miu Injection :
Should you forget a dose of Intalfa 3miu Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Intalfa 3miu Injection
| Label | Value |
|---|---|
| Chemical Type | Interferon proteins |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Active Class | Interferon signaling |
3,018 People bought this recently